BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This advanced composite hydrogel material features terpene-hybridized and indomethacin-loaded liposomes embedded within a semi-solid polymeric matrix template. The structural framework consists of a high-purity phospholipid vesicle core whose lipophilic tail domain is hybridized with terpene penetration enhancers (such as limonene or menthol) and encapsulates the hydrophobic indole derivative indomethacin, entirely dispersed within a highly cross-linked viscoelastic network of a hydrophilic polymer hydrogel. This complex configuration coordinates a highly fluid, terpene-modified lipid core with a dense macroscopic mechanical barrier, altering the overall matrix density and passive mass transfer resistance to completely prevent drug crystallization and physical vesicle aggregation across variable laboratory testing setups.
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.